{"abstract": "Documents in a fraud case against Pfizer suggest that research officials were less than forthcoming about the safety of the arthritis drug Celebrex during an early trial study.", "web_url": "https://www.nytimes.com/2012/06/25/health/in-documents-on-pain-drug-celebrex-signs-of-doubt-and-deception.html", "snippet": "Documents in a fraud case against Pfizer suggest that research officials were less than forthcoming about the safety of the arthritis drug Celebrex during an early trial study.", "lead_paragraph": "A research director for Pfizer was positively buoyant after reading that an important medical conference had just featured a study claiming that the new arthritis drug Celebrex was safer on the stomach than more established drugs.", "print_section": "A", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2012/06/25/business/jp-celebrex-1/jp-celebrex-1-articleLarge.jpg", "height": 330, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2012/06/25/business/jp-celebrex-1/jp-celebrex-1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 330}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/06/25/business/jp-celebrex-1/jp-celebrex-1-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/06/25/business/jp-celebrex-1/jp-celebrex-1-superJumbo.jpg", "height": 1365, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2012/06/25/business/jp-celebrex-1/jp-celebrex-1-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2012/06/25/business/jp-celebrex-1/jp-celebrex-1-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2012/06/25/business/jp-celebrex-1/jp-celebrex-1-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "In Documents on Pain Drug, Signs of Doubt and Deception", "kicker": null, "content_kicker": null, "print_headline": "Signs of Doubt and Deception In Documents on a Pain Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Heart", "rank": 1, "major": "N"}, {"name": "subject", "value": "ARTHRITIS", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 3, "major": "N"}, {"name": "subject", "value": "Celebrex (Drug)", "rank": 4, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 6, "major": "N"}], "pub_date": "2012-06-25T01:53:48+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/47a59ebf-c865-58fa-bcc8-b4b7c3c6485b", "word_count": 1465, "uri": "nyt://article/47a59ebf-c865-58fa-bcc8-b4b7c3c6485b"}